Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.
about
Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study.Hepatitis B virus management to prevent reactivation after chemotherapy: a review.Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis.The compliance of doctors with viral hepatitis B screening and antiviral prophylaxis in cancer patients receiving cytotoxic chemotherapy using a hospital-based screening reminder systemManagement of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma.Case report: passive transfer of hepatitis B antibodies from intravenous immunoglobulin.Hepatitis B reactivation and rituximab in the oncology practice.Prophylactic Effect of Lamivudine for Chemotherapy-Induced Hepatitis B Reactivation in Breast Cancer: A Meta-AnalysisSystematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation.Management of hepatitis B reactivation in patients receiving cancer chemotherapy.Clinical prediction of failure of Lamivudine prophylaxis for hepatitis B virus-infected patients undergoing cytotoxic chemotherapy for malignancy.Management of chronic hepatitis B: consensus guidelinesProphylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis.Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C.Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management.Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation.Should cirrhosis change our attitude towards treating non-hepatic cancer?Management of HBV in immunocompromised patients.Diagnosis and management of infectious complications of childhood rheumatic diseases.Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy.Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinoma.Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.Severe hepatitis C reactivation as an early complication of hematopoietic cell transplantation.Comparative effectiveness of nucleos(t)ide analogues in chronic hepatitis B patients undergoing cytotoxic chemotherapy.Radiation-induced hepatitis B virus reactivation in hepatocellular carcinoma: A case report.Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study.Preventing hepatitis B viral reactivation in patients receiving cancer chemotherapy.Management of HBV infection during immunosuppressive treatmentEffect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance.Current treatment indications and strategies in chronic hepatitis B virus infection.Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies.Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy.Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.Hepatitis B virus reactivation associated with temozolomide for malignant glioma: a case report and recommendation for prophylaxis.A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial.
P2860
Q30434625-3DC714F1-FEA9-49F3-B76B-B538F106BE6FQ33619636-C0161820-DE8D-4816-A174-1F383A157FACQ34397738-E5F3896E-B2AE-49A4-95ED-3BFBF74C1D62Q34734311-F89C7A9D-277D-45E1-9351-9E00083D716EQ35057889-7B3B2742-6B2D-49C7-AF86-7E890901DF34Q35095916-71AAC50F-C91A-46F0-9CE3-CE3459E6CFD4Q35100218-3D5AF8E0-A83A-41A8-88D2-BEB0BDED29A2Q35583718-973AC403-A4B5-440D-BDC1-187A1B9DB889Q35658261-F6C2083A-C473-4384-8A4E-3DBB6DA0CC7EQ36001152-627433F6-8E28-44E1-89DD-1690019DE93BQ36220459-BBA8C27E-7815-416A-8E76-63E4DF185CAEQ36364001-581958F0-6BFB-4A7E-8815-7183E30DE094Q36849343-8CEA7C62-24EF-4C1D-A399-2FC82CE34359Q36957087-8375AAC7-D087-44C5-8F4A-71F975CB8572Q37067589-F905E5E2-711F-4A02-9F9A-FB1242E0234DQ37124256-053ACF3F-3458-4B9C-B6D5-B61A51B23738Q37764963-9223989D-FA78-46CF-8A10-B0D076AA69C2Q37912229-E548796A-D16C-475C-A155-62F9525C3929Q37958071-AC29E41D-0996-4938-A513-3445AFE86EA3Q38071405-B6E437A5-ED09-45AA-89E3-A85A99A3C797Q38084889-CA3F28DC-ED16-4927-A82A-078D371F7F2BQ38218566-9A09AEC4-C09E-44A4-99F2-46D63B6E34DDQ38665203-9838C5CC-1B7A-4394-BDF1-AF3156655475Q38755178-75F3CC60-B647-4353-8C80-AE8B96174299Q40610203-90800F56-BDE7-45EC-A5E9-17CB83A26695Q40642803-39E4872B-B15B-4E91-86C8-C62DF10C0E10Q40848362-5A5BD5A0-C689-46FF-9DAE-A3819F204661Q41715901-4619D2A9-A749-453E-8FD4-9C99B54657F4Q41790668-D37B4F44-8CB5-4C6D-B4E6-B0847BB129D8Q41859437-EBA7A7A7-8452-4AED-B5BF-9A3DD5C61A67Q42145809-70C4099E-0B9D-4929-A646-94D3E1A1BC95Q42619923-A181826E-074E-4220-8AEC-2F83F553EB0DQ42952349-A46C8C89-F786-4576-9453-EDEB755FEFE2Q43275329-3EEC6C5B-46DD-4296-9300-A49754C858A2Q44242208-35D2DDCF-34C7-4C63-84C9-9A171E4F86D5Q45268408-7911E143-570C-43B0-B639-924A67502E21Q45364479-026CF71F-77B2-4B91-9260-1EB581AB118FQ45367828-3FEB4C17-3DCB-43E4-81F4-DA0EACA33E9AQ45388069-AF9B0A20-20C5-4377-AB1C-A0A3199DF72FQ46732231-E76CAAC3-9EFA-4C54-A6B9-2367CF19EA7E
P2860
Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Systematic review: lamivudine ...... c hepatitis B virus infection.
@ast
Systematic review: lamivudine ...... c hepatitis B virus infection.
@en
type
label
Systematic review: lamivudine ...... c hepatitis B virus infection.
@ast
Systematic review: lamivudine ...... c hepatitis B virus infection.
@en
prefLabel
Systematic review: lamivudine ...... c hepatitis B virus infection.
@ast
Systematic review: lamivudine ...... c hepatitis B virus infection.
@en
P2093
P2860
P1476
Systematic review: lamivudine ...... c hepatitis B virus infection.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2036.2006.03081.X
P407
P577
2006-10-01T00:00:00Z